Policy Report: TTIP and Affordable Medicines – How TTIP May Obstruct Progress Towards Sustainable Access To Medicines

Media Statement: HAI Response to Political Declaration of the United Nations High-level Meeting of the General Assembly on Antimicrobial Resistance

Media Statement: Health Action International Response to Report by UN High-level Panel on Access to Medicines

Open Letter to European Commision on June 2016 EU Council Conclusions

56 Non-profit Organisations Question US State Department Pressure Against Global Access to Medicines Initiatives – Letter to US Secretary of State, John Kerry

Recommendations for EU Governments to Improve Access & Innovation of Needed Medicines

Private Patents and Public Health: Changing intellectual property rules for access to medicines

Measures That Reduced Price of Patented HIV Medicines Should Be Used to Safeguard Access to New Essential Medicines

EU Trade Policy & Access to Medicines

EU Trade Policy & Access to Medicines

HAI Provides EU Member States with Recommendations that Promote Therapeutically Advantangeous and Affordable Medicines

Civil Society Urges Member States to Defend Need for Critical Review of IP System and Incentives for Medical Innovation

WHA69 Intervention on Global Medicine Shortages and the Safety and Accessibility of Children’s Medication

HAI and KEI Submit WHA69 Intervention on Follow-up CEWG Report

HAI Co-signs Letter to Obama Administration Regarding Alleged U.S. Interference in Colombian Health Measure

HAI Submits Intervention on Establishing a Global Development and Stewardship Framework for Antimicrobial Medicines and Other Interventions at WHA69

Snakebite: Call for urgent global action to end death & suffering

HAI, KEI & STOPAIDS Statement on the WHO Consultative Expert Working Group on R&D

Measuring Medicine Prices, Availability, Affordability and Price Components (2nd Ed.)

Civil Society Urges Member States to Support the Dutch EU Presidency’s Vision on Access to Affordable Medicines

Trade Secrets Directive Will Threaten Access to Medicines Safety and Efficacy Data

Insulin Trade Profile

ACCISS Study Reveals Numerous Barriers Hindering Access to Insulin for Millions in Need

HAI Intervention on Ensuring Access to Antimicrobial Drugs, Diagnostics and Vaccines

Assessing EU Funding for R&D for Poverty-related and Neglected Diseases

HAI Intervention at the United Nations High-Level Panel on Access to Medicines

Access to High-priced Medicines in Hospital Settings in Europe: A Study in Four European Countries

Study Finds Access to High-priced Medicines May Differ Across EU

Why You Should Be Concerned About TTIP and Access to Medicines

Listen: ACCISS Study Investigator, David Beran, Speaks to The Lancet D&E About Insulin Access